肾细胞癌疫苗：我们正在接近现实吗？ - Suppr

Suppr

超能文献

A vaccine in renal cell carcinoma: are we nearing reality?

作者信息

Bedke Jens, Gouttefangeas Cécile, Kruck Stephan, Stenzl Arnulf

出版信息

Expert Rev Anticancer Ther. 2012 Dec;12(12):1503-5. doi: 10.1586/era.12.139.

DOI:10.1586/era.12.139

PMID:23253216

Abstract

摘要

相似文献

A vaccine in renal cell carcinoma: are we nearing reality?

Expert Rev Anticancer Ther. 2012 Dec;12(12):1503-5. doi: 10.1586/era.12.139.

Vaccines for colorectal cancer and renal cell carcinoma.

Cancer J. 2011 Sep-Oct;17(5):283-93. doi: 10.1097/PPO.0b013e318232ff44.

Autologous renal cell cancer vaccines using heat shock protein-peptide complexes.

Urol Oncol. 2006 Sep-Oct;24(5):425-33. doi: 10.1016/j.urolonc.2005.08.009.

Relapse of renal cell carcinoma with disappearance of HLA class I following hTERT peptide vaccination.

Ann Oncol. 2010 Oct;21(10):2122-2124. doi: 10.1093/annonc/mdq544.

TroVax(®) vaccine therapy for renal cell carcinoma.

Immunotherapy. 2012 Jan;4(1):27-42. doi: 10.2217/imt.11.160.

Vaccines in renal cell carcinoma.

Semin Oncol. 2006 Oct;33(5):614-24. doi: 10.1053/j.seminoncol.2006.06.011.

Cell fusion technology vaccine tested in kidney cancer clinical trial.

Expert Rev Anticancer Ther. 2002 Dec;2(6):620.

Tailor-made renal cell carcinoma vaccines.

Cancer Cell. 2012 Sep 11;22(3):287-9. doi: 10.1016/j.ccr.2012.08.021.

Specific antitumour vaccine for renal cancer.

Lancet. 2004 Feb 21;363(9409):583-4. doi: 10.1016/S0140-6736(04)15625-0.

Ex vivo gene therapy using granulocyte-macrophage colony-stimulating factor-transduced tumor vaccines.

Mol Urol. 2000 Summer;4(2):43-6. doi: 10.1089/10915360050138567.

引用本文的文献

How far is the horizon? From current targets to future drugs in advanced renal cancer.

World J Urol. 2014 Feb;32(1):69-77. doi: 10.1007/s00345-013-1096-1. Epub 2013 May 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A vaccine in renal cell carcinoma: are we nearing reality?

Expert Rev Anticancer Ther. 2012 Dec;12(12):1503-5. doi: 10.1586/era.12.139.

Vaccines for colorectal cancer and renal cell carcinoma.

Cancer J. 2011 Sep-Oct;17(5):283-93. doi: 10.1097/PPO.0b013e318232ff44.

Autologous renal cell cancer vaccines using heat shock protein-peptide complexes.

Urol Oncol. 2006 Sep-Oct;24(5):425-33. doi: 10.1016/j.urolonc.2005.08.009.

Relapse of renal cell carcinoma with disappearance of HLA class I following hTERT peptide vaccination.

Ann Oncol. 2010 Oct;21(10):2122-2124. doi: 10.1093/annonc/mdq544.

TroVax(®) vaccine therapy for renal cell carcinoma.

Immunotherapy. 2012 Jan;4(1):27-42. doi: 10.2217/imt.11.160.

Vaccines in renal cell carcinoma.

Semin Oncol. 2006 Oct;33(5):614-24. doi: 10.1053/j.seminoncol.2006.06.011.

Cell fusion technology vaccine tested in kidney cancer clinical trial.

Expert Rev Anticancer Ther. 2002 Dec;2(6):620.

Tailor-made renal cell carcinoma vaccines.

Cancer Cell. 2012 Sep 11;22(3):287-9. doi: 10.1016/j.ccr.2012.08.021.

Specific antitumour vaccine for renal cancer.

Lancet. 2004 Feb 21;363(9409):583-4. doi: 10.1016/S0140-6736(04)15625-0.

Ex vivo gene therapy using granulocyte-macrophage colony-stimulating factor-transduced tumor vaccines.

Mol Urol. 2000 Summer;4(2):43-6. doi: 10.1089/10915360050138567.

引用本文的文献

How far is the horizon? From current targets to future drugs in advanced renal cancer.

World J Urol. 2014 Feb;32(1):69-77. doi: 10.1007/s00345-013-1096-1. Epub 2013 May 9.